Reston, VA — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2022 Annual Meeting, held June 11-14.
Credit: Courtesy of SNMMI
Reston, VA — Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, has been named president-elect for the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI introduced a new slate of officers during its 2022 Annual Meeting, held June 11-14.
“As SNMMI president-elect, I plan to focus on the future of the field,” said Nadel. “How can we be prepared for future health crises? What can we do to fast-track the development and approval of diagnostic and theranostic molecular imaging agents? How can we ensure diversity in all parts of the nuclear medicine family?”
Working with SNMMI members, task forces and committees, Nadel will bring these issues to the forefront of the society’s agenda and will develop programs to address them. Projects will include creating rapid global communication and mobilization plans, fostering the society’s government and industry relationships, and implementing diversity initiatives.
Nadel earned her medical degree from the University of Manitoba in Winnipeg, Manitoba, Canada, in 1977. She completed a diagnostic radiology residency in 1982 at the University of Toronto, followed by a fellowship in pediatric radiology at the Hospital for Sick Children at the University of Toronto, both in Toronto, Ontario, Canada. She then completed a nuclear medicine residency in 1989 at the University of British Columbia, in Vancouver, British Columbia, Canada. Nadel held multiple academic appointments at the University of British Columbia between 1983 and 2018 and was head of the division of nuclear medicine and department of radiology at British Columbia Children’s Hospital before taking on her current roles at Stanford.
Nadel has been an active SNMMI member for more than 30 years, serving as vice president-elect and in the House of Delegates. She also held positions as president of the Pediatric Imaging Council and member of its board of directors, and she has served on the PET Center of Excellence Board of Directors, Scientific Program Committee, Membership Committee and The Journal of Nuclear Medicine Editorial Board, among other posts. She was president of the SNMMI Pacific Northwest Chapter for many years and currently plays an active role in the Northern California chapter.
In the greater nuclear medicine community, Nadel has served in multiple positions for the American College of Nuclear Medicine, the American Board of Nuclear Medicine, the Radiological Society of North America, and the Children’s Oncology Group. In 2019, Nadel received the Lifetime Achievement Award from the European Society of Pediatric Nuclear Medicine for ongoing contributions to pediatric nuclear medicine. She has published 76 peer-reviewed journal articles and 24 book chapters and has been an invited speaker for 180 presentations.
Other SNMMI officers elected for 2022-23 are Munir Ghesani, MD, FACNM, FACR, New York, New York, as president and Cathy Sue Cutler, PhD, FSNMMI, Upton, New York, as vice president-elect. SNMMI Technologist Section officers for 2022-23 are Krystle W. Glasgow, MIS, CNMT, NMTCB(CT), NMAA, FSNMMI-TS, Birmingham, Alabama, as president and Dmitry Beyder, CNMT, MPA, St. Louis, Missouri, as president-elect.
###
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.
